Utilization of Peptide Carrier System To Improve Intestinal Absorption: Targeting Prolidase as a Prodrug-Converting Enzyme
- 1 February 1992
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 81 (2) , 113-116
- https://doi.org/10.1002/jps.2600810202
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Structural Requirements for the Intestinal Mucosal-Cell Peptide Transporter: The Need for N-Terminal α-Amino GroupPharmaceutical Research, 1991
- Use of the Peptide Carrier System to Improve the Intestinal Absorption of L-α-Methyldopa: Carrier Kinetics, Intestinal Permeabilities, and In Vitro Hydrolysis of Dipeptidyl Derivatives of L-α-MethyldopaPharmaceutical Research, 1989
- Effect of long preincubation on the two forms of human erythrocyte prolidaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1987
- Inhibition of rat and human prolidases by captoprilBiochemical Pharmacology, 1985
- Prolidase and prolidase deficiencyLife Sciences, 1984
- Developmental changes in the activities of prolinase and prolidase in rat salivary glands, and the effect of thyroxine administrationMolecular and Cellular Biochemistry, 1982
- Activation and Inhibition of Cerebral ProlidaseJournal of Neurochemistry, 1980
- PROLIDASE ACTIVITY IN BRAIN: COMPARISON WITH OTHER ORGANSJournal of Neurochemistry, 1978
- Covalent coupling of calf brain prolidaseJournal of Neuroscience Research, 1977
- Structural properties of pig intestinal proline dipeptidaseBiochimica et Biophysica Acta (BBA) - Protein Structure, 1974